Masashi Shingai

Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells

Misako Matsumoto, Kenji Funami, Masako Tanabe et al. · The Journal of Immunology · 2003 · 699 citations · Full text

Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

Masashi Shingai, Yoshiaki Nishimura, Florian Klein et al. · Nature · 2013 · 450 citations · Full text

Vaccination, Viral Persistence, Pathogenesis +7

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

Masashi Shingai, Olivia K. Donau, Ronald J. Plishka et al. · The Journal of Experimental Medicine · 2014 · 327 citations · Full text

Immunology, Immunodominance, Immunotherapeutics +18

Early antibody therapy can induce long-lasting immunity to SHIV

Yoshiaki Nishimura, Rajeev Gautam, Tae‐Wook Chun et al. · Nature · 2017 · 307 citations · Full text

Veterinary Vaccine, Immunology, Virology +5

Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells

Takashi Akazawa, Takashi Ebihara, Manabu Okuno et al. · Proceedings of the National Academy of Sciences · 2006 · 185 citations · Full text

Immunology, Toll-like Receptor, Cell Death +19